Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Anticancer Drugs. 2015 Feb;26(2):167–179. doi: 10.1097/CAD.0000000000000173

Figure 11.

Figure 11

Angiogenic responses of human umbilical vascular endothelial cells (HUVEC) to PTX treatment. A. HUVECs treated for 24 hrs by PTX at 0 (vehicle control), 5 nM, 25 nM, and 50 nM in the DMSO or RUB solubilization systems. B. Migration assay of HUVEC stimulated with 4 ng/mL vascular endothelial growth factor. HUVECs were scraped from the center and treated for 6 hrs by PTX at 0 (vehicle control), 5 nM, 25 nM, and 50 nM in the DMSO or RUB solubilization systems.